Search

Objective: To survey (a) the frequency of the use of patient-controlled analgesic remifentanil-PCA during labour in the Netherlands; (b) considerations by obstetricians whether or not to offer remifentanil-PCA; (c) target population for remifentanil-PCA and (d) the application of maternal monitoring., Design: Descriptive survey., Method: A questionnaire was sent to all 81 Dutch hospitals with a labour ward. The following subjects were covered: (a) available methods for pharmacological pain relief; (b) considerations by obstetricians whether or not to offer remifentanil-PCA; (c) target population for remifentanil-PCA; (d) maternal monitoring and (e) the hospital's birth data for the year 2016. The hospital pharmacist was asked for the number of remifentanil dispensed in 2016-2017., Results: The questionnaire was completed by 81 obstetricians (100% response rate). Remifentanil-PCA was available in 59 out of 81 (73%) of the hospitals with a mean use of 23% of the births (range 16-56%) in those units. In 34 (58%) of these hospitals, remifentanil-PCA is available for all women, and in 25 (42%) it was for a selected group of women. Most frequently mentioned considerations for offering remifentanil-PCA were 'a need for an alternative for epidural analgesia' and 'at the request of pregnant women' reported a respective 55 (93%) and 46 (78%) times. In hospitals where remifentanil-PCA was not offered, the following motives were given for this policy: 'epidural analgesia is the most effective method of pain relief during labour'; 'risk of serious maternal complications'; and 'sufficient monitoring during labour not feasible in delivery rooms'., Conclusion: A large variation between Dutch hospitals exists in the application of remifentanil-PCA during labour. In the majority of the hospitals, remifentanil-PCA is available for all women. The most common motives mentioned by obstetricians for its use are 'a need for an alternative for epidural analgesia' and 'at the request of pregnant women'.

Objective: To determine the objective of scientific association proceedings in the Nederlands Tijdschrift voor Geneeskunde (NTvG) and whether the objective is met by publication., Design: Interview., Setting: The editorial office of NTvG MATERIAL AND METHODS: The clinical relevancy of the proceedings published in 1990 and 1991 was determined using selection criteria. 53 (former) secretaries of scientific associations which publish their proceedings in NTvG were interviewed by written questionnaire, and 101 physicians were interviewed by telephone, asking for their opinion on the objective and the use of publishing the proceedings., Results: Of the proceedings (1610 abstracts) published in 1990 and 1991 20% were considered clinically relevant. The opinion of the secretaries of the associations was that the objective of the proceedings is to record medical information and to provide a medical newspaper for the latest reports of the associations, mostly intended for all readers of the NTvG. The secretaries usually correct the abstracts with respect to form and to a lesser extent to informative value. Editorial office selection of the abstracts was not considered desirable, guidelines with regard to writing an abstract of the proceedings were appreciated. More than half of the family physicians read the proceedings, but often considered them too specialised. Half of these thought editorial office selection of the abstracts advisable. About 80% of the specialists read the proceedings, of which the informative value was considered variable. They disapproved of editorial selection. In general physicians read the proceedings very selectively., Conclusions: The clinical relevancy of the abstracts of the proceedings leaves much to be desired. The objective is to provide a medical record and a newspaper for all readers, but these read the proceedings very selectively. The informative value could be improved. Abstract selection should be in the hands of the associations' secretaries only, but guidelines from the editorial office on writing abstracts are welcomed.